Gonzaga, Serapio A.
HRN: 21-88-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/06/2022
CEFTAZIDIME 1GM (VIAL)
09/06/2022
09/12/2022
IV
1gm
TID
CAP MR; PTB Presumptive
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes